Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Oocyte Cryopreservation
100%
Fertility Preservation
73%
Ovarian Tissue Transplantation
67%
Spermatozoa
46%
Intracytoplasmic Sperm Injection
41%
Sperm Selection
40%
Primordial Follicle
39%
Non-obstructive Azoospermia
38%
Cycle Outcomes
37%
Frozen-thawed
36%
Cryopreserved
35%
Cryopreservation
33%
Sperm Preparation
32%
Anti-Müllerian Hormone
32%
Hyaluronic Acid Binding
32%
Sertoli Cells
32%
Transplantation
30%
Follicle Loss
30%
Ovarian Tissue
30%
Controlled Ovarian Stimulation
28%
Follicle-stimulating Hormone
27%
Live Birth
26%
Cancer Treatment
25%
Gonad
23%
Hyaluronic Acid
23%
HSPA2
23%
Random Start
21%
Testicular Sperm
21%
Preparation Method
21%
Nilotinib
21%
Ovarian Response
21%
Human Spermatozoa
21%
Mouse Model
21%
Cancer Patients
21%
Motility
21%
Freeze-thaw
20%
Anti-mullerian Hormone Levels
19%
Cancer Therapy
19%
Primordial Follicle Reserve
17%
Gonadotoxic
17%
Density Gradient
17%
Vitrification
17%
Swim-up
17%
Ovarian Stimulation
16%
Zona Pellucida
16%
Stimulation Cycle
16%
Human Sperm
16%
Ovarian Reserve
15%
Early Referral
15%
Chronic Myeloid Leukemia
15%
Medicine and Dentistry
Oocyte
74%
Fertility Preservation
68%
Ovarian Tissue Cryopreservation
58%
Follicle
48%
Cryopreservation
46%
Primordial Follicle
38%
Vitrification
34%
Muellerian Inhibiting Factor
32%
In Vitro
32%
Cancer Therapy
32%
Intracytoplasmic Sperm Injection
30%
Controlled Ovarian Hyperstimulation
30%
Tissue Transplantation
29%
Malignant Neoplasm
28%
Oocyte Cryopreservation
27%
Diethylstilbestrol
24%
Breast Cancer
23%
Restylane
21%
Nilotinib
21%
Blastocyst
21%
Follitropin
19%
Antral Follicle
19%
Gonad
18%
Hormone Determination
16%
Reproductive Medicine
16%
Chronic Myelogenous Leukemia
15%
Spermiogenesis
15%
Fertilization
15%
Embryo Quality
15%
Supplementation
14%
Pentoxifylline
14%
Sperm Motility
14%
Embryo Transfer
14%
Assisted Reproductive Technology
14%
Diseases
14%
Tail
13%
Histone
12%
Oocyte Retrieval
12%
Rapamycin
12%
Acute Lymphoblastic Leukemia
12%
DNA Fragmentation
12%
Programmed Cell Death
11%
Chemotherapy
11%
Zona Pellucida
11%
Patient Referral
10%
Stem Cell
10%
Cell Protein
10%
Letrozole
10%
Hormone Therapy
10%
Lecithinase
10%